Production of IL 2 and IFN-gamma by T Cells from Malaria Patients in Response to Plasmodium Falciparum or Erythrocyte Antigens in Vitro
Overview
Authors
Affiliations
T cells from patients acutely infected with malaria exhibit a disease-related stimulation of DNA synthesis in response to Plasmodium falciparum antigen in vitro. This response is weak and short-lived, suggestive of induction of suppressor mechanisms. Exogenous T cell growth factor (IL 2) that was added to antigen-stimulated T cell cultures enhanced proliferation in antigen-responsive cultures, indicating that the lymphocytes expressed IL 2 receptors. In contrast, the addition of IL 2 to cultures that did not respond to antigen had no effect. Antigen-responsive cultures contained endogenous IL 2 as well, and the antigen-induced lymphocyte proliferation was correlated with IL 2 production. However, the results suggested that IL 2 production by the patients' T cells was insufficient or actively shut off, and that this was responsible for the premature cessation of their DNA synthesis. Supernatants from 60% of the T cell cultures treated with malaria antigen and from 30% treated with RBC ghost antigen contained interferon-gamma (IFN-gamma), as determined by a cytopathic effect inhibition assay combined with acid treatment and antibody neutralization or by an IFN-gamma-specific ELISA. There was no obvious correlation between antigen-induced lymphocyte proliferation and the presence of IFN-gamma in the culture supernatants. A high IFN-gamma activity was also seen in antigen-treated cultures from P. falciparum-immune donors living in highly endemic malaria areas. In contrast, no IFN-gamma was found in supernatants of antigen-treated T cells from healthy donors or patients with Plasmodium vivax malaria. Thus, the IFN-gamma activity of these cultures appears to reflect the presence of antigen-reactive T cells and may be useful as a sensitive indicator of cellular immunity in P. falciparum malaria.
Browne D, Kelly A, Brady J, Proietti C, Sarathkumara Y, Pattinson D Sci Rep. 2023; 13(1):21071.
PMID: 38030676 PMC: 10687243. DOI: 10.1038/s41598-023-48066-9.
Amo L, Kole H, Scott B, Qi C, Krymskaya L, Wang H Front Immunol. 2023; 14:1192819.
PMID: 37539049 PMC: 10394379. DOI: 10.3389/fimmu.2023.1192819.
T cell-mediated immunity to malaria.
Kurup S, Butler N, Harty J Nat Rev Immunol. 2019; 19(7):457-471.
PMID: 30940932 PMC: 6599480. DOI: 10.1038/s41577-019-0158-z.
CD4 T-cell subsets in malaria: TH1/TH2 revisited.
Perez-Mazliah D, Langhorne J Front Immunol. 2015; 5:671.
PMID: 25628621 PMC: 4290673. DOI: 10.3389/fimmu.2014.00671.
Costa A, Antonelli L, Costa P, Pimentel J, Garcia N, Tarrago A J Immunol Res. 2014; 2014:318250.
PMID: 24741587 PMC: 3987793. DOI: 10.1155/2014/318250.